Abstract
Only about 50% of central pain patients respond to motor cortex stimulation in the long run. There is a need for prognostic factors. Here we show that propofol test and TMS both predict short-term effect in nine patients with central pain. This may help reduce the number of failures.
MeSH terms
-
Adult
-
Aged
-
Electric Stimulation Therapy / methods*
-
Female
-
Humans
-
Hypnotics and Sedatives
-
Magnetics / therapeutic use*
-
Male
-
Middle Aged
-
Motor Cortex / physiology*
-
Pain / diagnosis
-
Pain Management*
-
Pilot Projects
-
Predictive Value of Tests
-
Propofol
Substances
-
Hypnotics and Sedatives
-
Propofol